ATH - Alterity Therapeutics

[Joules MM1]

not a holder of this, ardent follower of their progress, current holders getting all the right news
again today, just need decent progress in the development

 

[Joules MM1]

prob a pop for a cupla of fractions, this needs trend to interest money that matters
...interesting news tho

ATH434 Reverses Colorectal Dysfunction in the A53T Mouse Model of Parkinson’s Disease - IOS Press

Background: Gastrointestinal (GI) complications, that severely impact patient quality of life, are a common occurrence in patients with Parkinson’s disease (PD). Damage to enteric neurons and the accumulation of alpha-synuclein in the enteric nervous

content.iospress.com

 

[frugal.rock]

Have noticed a few US biotechs popping over the last few nights.
Alterity (ATHE) on the NASDAQ is currently up 37% pre market.

I'm assuming it's the same company, dual listed or more?

It's a horrible chart really, but today's bar may be the reversal, or not?
There was a US patent granted announcement today.
Not my cup of tea without any DD/FA but may be interesting to watch.

 

[greggles]

Some encouraging news today for ATH with its FDA application to conduct its Phase 2 clinical trials in the US having been approved.

ATH's share price has been in a year long downtrend that seems to have formed a bottom around 1.5c just recently. This news has sent it north again, but it is just the first step in a long, complicated, capital intensive process so management will need to kick some goals in the form of partnership agreements or industry support to generate some positive sentiment and fire up the share price even further.

 

[Miner]

It is almost six months since the last post was from @greggles
ATH has released a SPP @0.035, which reportedly was well received by fundies. Bank of NY has increased its stake by about 2% by subscribing to SPP, but why did they increase their holding to 43%, affecting the liquidity unless they smelled something on the testing, which the market has not yet anticipated?
Friday's volume was considerably higher than previous days. Was it to make the SPP acquisition by the retailers attractive?
The price suddenly jumped by 25%, presumably the profit takers to encash tomorrow.

https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02758944-3A634124 SPP OFFER

https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02762007-3A634585 - Bank of NY
The same bank unloaded heaps on 8 January https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02761283-3A634442
Regal Fund acquired 5%

https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02761601-3A634498

https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02761928-3A634573 - Directors through SPP

 

[Dona Ferentes]

It is almost six months since the last post was from @greggles
ATH has released a SPP @0.035, which reportedly was well received by fundies. ...

money down ... now $0.006

and that's after a jump from $0.003 when reporting on progress on Phase II trial

three year, weekly chart